Literature DB >> 655729

Inhibition of eucaryotic DNA polymerases by phosphonoacetate and phosphonoformate.

C L Sabourin, J M Reno, J A Boezi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 655729     DOI： 10.1016/0003-9861(78)90010-3

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN： 0003-9861            Impact factor:   4.013


× No keyword cloud information.
  11 in total

1.  Inhibition of human immunodeficiency virus reverse transcriptase by 2',3'-dideoxynucleoside triphosphates: template dependence, and combination with phosphonoformate.

Authors:  M C Starnes; Y C Cheng
Journal:  Virus Genes       Date:  1989-05       Impact factor: 2.332

2.  Concentration-dependent effects of foscarnet on the cell cycle.

Authors:  K Stenberg; S Skog; B Tribukait
Journal:  Antimicrob Agents Chemother       Date:  1985-12       Impact factor: 5.191

Review 3.  DNA polymerases in prokaryotes and eukaryotes: mode of action and biological implications.

Authors:  U Hübscher
Journal:  Experientia       Date:  1983-01-15

4.  Structure-activity studies on phosphonoacetate.

Authors:  J C Mao; E R Otis; A M von Esch; T R Herrin; J S Fairgrieve; N L Shipkowitz; R G Duff
Journal:  Antimicrob Agents Chemother       Date:  1985-02       Impact factor: 5.191

Review 5.  Foscarnet. A review of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with cytomegalovirus retinitis.

Authors:  P Chrisp; S P Clissold
Journal:  Drugs       Date:  1991-01       Impact factor: 9.546

6.  Reversible effects on cellular metabolism and proliferation by trisodium phosphonoformate.

Authors:  K Stenberg; A Larsson
Journal:  Antimicrob Agents Chemother       Date:  1978-11       Impact factor: 5.191

7.  Hepatitis-B virus-associated deoxyribonucleic acid polymerase: a partial characterization by the use of chemical agents.

Authors:  G Hess; W Arnold; K H Meyer zum Büschenfelde
Journal:  Klin Wochenschr       Date:  1981-06-15

8.  In vitro and in vivo inhibition of myxoma virus by treatment with phosphonoacetic acid.

Authors:  J M Goodrich; K W Lee; H C Hinze
Journal:  Arch Virol       Date:  1981       Impact factor: 2.574

9.  In vitro inhibition of Herpesvirus sylvilagus by phosphonoacetic acid and phosphonoformate.

Authors:  J M Goodrich; K W Lee; H C Hinze
Journal:  Arch Virol       Date:  1980       Impact factor: 2.574

10.  Genetic evidence for vaccinia virus-encoded DNA polymerase: isolation of phosphonoacetate-resistant enzyme from the cytoplasm of cells infected with mutant virus.

Authors:  B Moss; N Cooper
Journal:  J Virol       Date:  1982-08       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.